ACCPL logo

Accretion Pharma Limited

ACCPL·NSE·
207.00 +0.00 (+0.00%)
Market Cap221.82 Cr
PE Ratio23.79
Volume1,200
Day High - Low207.00 - 207.00
52W High-Low214.70 - 53.80
DocStoX Score
7.3/10
Strong
Fair Value
Sign in to see
ROE
44.44%
Strong
P/E
23.79x
Fair
Debt / Equity
0.23
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Strong

Price performance

52W53.80
214.70
DocStoX take

Supported by growth (10.0) and momentum (7.5), but weakest on risk (6.0).

DocStoX score

Low confidence
7.3
/10
Strong
Quality
Solid
ROE 44.4%
Valuation
Fair
P/E 23.8×
Growth
Strong
Revenue +45.0% 3Y CAGR
Risk
Moderate
D/E 0.23
Momentum
Strong
95% of 52-week range

At a glance

Market Cap
₹222 Cr
52W High / Low
₹215 / ₹54
Dividend Yield
0.00%
Promoter Holding
73.52%
EPS (TTM)
₹8.70
Book Value
₹49.21

Key highlights

  • Profit compounding 359% a year
  • Revenue compounding 45% a year
  • Strong returns on equity (44%)
  • Small ₹222 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ACCRETION PHARMA LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.